16 results
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
24 May 22
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-3.2
ATRS
Antares Pharma, Inc.
24 May 22
Entry into a Material Definitive Agreement
4:22pm
SC14D9C
EX-3.1
ATRS
Antares Pharma, Inc.
13 Apr 22
Written communication relating to third party tender offer
12:30pm
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
13 Apr 22
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
9:21am
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
28 May 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-3
qplmg
19 May 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3
sp12qqqmpli ks1y
15 May 07
Other Events
12:00am
10-K405
EX-3.5
3ipb ntontu3tmi4xn
16 Apr 01
Annual report (delinquent filer disclosure)
12:00am
10-K405
EX-3.1
q8k1n28s6tl hbvn
16 Apr 01
Annual report (delinquent filer disclosure)
12:00am
10-K405
EX-3.3
4b8m1ujcrzcc6n8zkmbb
31 Mar 99
Annual report (delinquent filer disclosure)
12:00am
S-1/A
EX-3.3
q9kaioxa
15 Aug 96
IPO registration (amended)
12:00am
S-1/A
EX-3.4
db3wd36siv90ve79yd8
15 Aug 96
IPO registration (amended)
12:00am
S-1
EX-3.2
0a6mvz bvzdbes8seq5
24 Jun 96
IPO registration
12:00am
S-1
EX-3.1
5cr3npm6428u8mhf8j
24 Jun 96
IPO registration
12:00am
- Prev
- 1
- Next